Researchers launch startup to bring novel treatments to patients with asthma and COPD

BIO5 Members Julie Ledford, Josef Vagner, Stefano Guerra, and Michael D.L. Johnson co-developed an innovative inhaled asthma/COPD therapy licensed to Aspiro Therapeutics.